Trometamol or tromethamine

This classification denotes an organic carcinogen with the molecular formula C4H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 023C2WHX2V, chemically known as 1,1,1-tris(hydroxymethyl)methanamine but generally known as trometamol, which bears US NIH Compound Identifier 6503. European Medicines Agency schedules Trometamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11336MIG. The term TROMETAMOL is an International Non-Proprietary Name. World Health Organization schedules trometamol in its Anatomical Therapeutic Chemical (ATC) Classification. TROMETAMOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tromethamine under HS 29221990 and SITC 51461. As of Q4 2014, TROMETHAMINE remains the US FDA Preferred Term for this commodity. Tromethamine bears US NLM identifiers UMLS ID C0041175 and NCI Concept Code C47775. SMILES: OCC(N)(CO)CO.